Development of a risk model based on immune genes in patients with colon adenocarcinoma

BACKGROUND: The rapidly increasing morbidity and the poor prognosis making the colon adenocarcinoma not only common but also highly malignant. On the other hand, immunotherapy emerges as a therapeutic modality of colon cancer recently. In this study, we developed a prognostic risk model that is base...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Laiming, Xu, Jing, Hu, Xueyou, Lyu, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939989/
https://www.ncbi.nlm.nih.gov/pubmed/36058633
http://dx.doi.org/10.1002/cnr2.1712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939989/
https://www.ncbi.nlm.nih.gov/pubmed/36058633
http://dx.doi.org/10.1002/cnr2.1712

Ejemplares similares